Your search returned 688 results.

Results
	241.	Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects. [electronic resource] by Davis, John D Hackman, Frances Layton, Gary Higgins, Tracy Sudworth, David Weissgerber, Georges Producer: 20080723 In: British journal of clinical pharmacology vol. 65 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	242.	CCR5 inhibitors: emergence, success, and challenges. [electronic resource] by Maeda, Kenji Das, Debananda Nakata, Hirotomo Mitsuya, Hiroaki Producer: 20121017 In: Expert opinion on emerging drugs vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	243.	Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques. [electronic resource] by Malcolm, R Karl Forbes, Claire J Geer, Leslie Veazey, Ronald S Goldman, Laurie Klasse, Per Johan Moore, John P Producer: 20130722 In: The Journal of antimicrobial chemotherapy vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	244.	HIV-1 subtype C predicted co-receptor tropism in Africa: an individual sequence level meta-analysis. [electronic resource] by Matume, Nontokozo D Tebit, Denis M Bessong, Pascal O Producer: 20210112 In: AIDS research and therapy vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	245.	Entry inhibitors in the treatment of HIV-1 infection. [electronic resource] by Tilton, John C Doms, Robert W Producer: 20100329 In: Antiviral research vol. 85 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	246.	R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies. [electronic resource] by Loftin, Lamorris M Kienzle, Martha Yi, Yanjie Collman, Ronald G Producer: 20110427 In: Journal of translational medicine vol. 9 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	247.	Use of cellular HIV DNA to predict virologic response to maraviroc: performance of population-based and deep sequencing. [electronic resource] by Swenson, Luke C Dong, Winnie W Y Mo, Theresa Demarest, James Chapman, Doug Ellery, Suzanne Heera, Jayvant Valdez, Hernan Poon, Art F Y Harrigan, P Richard Producer: 20140319 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	248.	Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 study. [electronic resource] by Cuzin, Lise Trabelsi, Selma Delobel, Pierre Barbuat, Claudine Reynes, Jacques Allavena, Clotilde Peytavin, Gilles Ghosn, Jade Lascoux-Combe, Caroline Psomas, Christina Corbeau, Pierre Flandre, Philippe Producer: 20130204 In: Journal of acquired immune deficiency syndromes (1999) vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	249.	Blockade of the chemokine receptor, CCR5, reduces the growth of orthotopically injected colon cancer cells via limiting cancer-associated fibroblast accumulation. [electronic resource] by Tanabe, Yamato Sasaki, Soichiro Mukaida, Naofumi Baba, Tomohisa Producer: 20180313 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	250.	Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model. [electronic resource] by Moss, John A Butkyavichene, Irina Churchman, Scott A Gunawardana, Manjula Fanter, Rob Miller, Christine S Yang, Flora Easley, Jeremiah T Marzinke, Mark A Hendrix, Craig W Smith, Thomas J Baum, Marc M Producer: 20171002 In: Antimicrobial agents and chemotherapy vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	251.	Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir. [electronic resource] by Dobard, Charles W Taylor, Andrew Sharma, Sunita Anderson, Peter L Bushman, Lane R Chuong, Dinh Pau, Chou-Pong Hanson, Debra Wang, Lin Garcia-Lerma, J Gerardo McGowan, Ian Rohan, Lisa Heneine, Walid Producer: 20160308 In: The Journal of infectious diseases vol. 212 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	252.	Association between a Suppressive Combined Antiretroviral Therapy Containing Maraviroc and the Hepatitis B Virus Vaccine Response. [electronic resource] by Herrero-Fernández, Inés Pacheco, Yolanda M Genebat, Miguel Rodriguez-Méndez, María Del Mar Lozano, María Del Carmen Polaino, María José Rosado-Sánchez, Isaac Tarancón-Diez, Laura Muñoz-Fernández, María Ángeles Ruiz-Mateos, Ezequiel Leal, Manuel Producer: 20190417 In: Antimicrobial agents and chemotherapy vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	253.	Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial. [electronic resource] by Pressiat, Claire Hirt, Déborah Treluyer, Jean-Marc Zheng, Yi Morlat, Philippe Naqvi, Alice Tran, Laurent Viard, Jean-Paul Avettand-Fenoel, Véronique Rouzioux, Christine Meyer, Laurence Cheret, Antoine Producer: 20190514 In: The Journal of antimicrobial chemotherapy vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	254.	Maraviroc observational study: the impact of expanded resistance testing and clinical considerations for antiretroviral regimen selection in treatment-experienced patients. [electronic resource] by Willig, James H Wilkins, Sara-Anne Tamhane, Ashutosh Nevin, Christa R Mugavero, Michael J Raper, James L Napolitano, Laura A Saag, Michael S Producer: 20130605 In: AIDS research and human retroviruses vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	255.	Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: a report of three cases. [electronic resource] by Righi, E Londero, A Pea, F Bonora, S Nasta, P Della Siega, P Delle Foglie, P Villa, G Giglio, O Dal Zoppo, S Baccarani, U Bassetti, M Producer: 20170413 In: Transplant infectious disease : an official journal of the Transplantation Society vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	256.	Potential anti-inflammatory effects of maraviroc in HIV-positive patients: a pilot study of inflammation, endothelial dysfunction, and coagulation markers. [electronic resource] by Francisci, Daniela Falcinelli, Emanuela Baroncelli, Silvia Petito, Eleonora Cecchini, Enisia Weimer, Liliana Elena Floridia, Marco Gresele, Paolo Baldelli, Franco Producer: 20150223 In: Scandinavian journal of infectious diseases vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	257.	Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individuals. [electronic resource] by Mora-Peris, Borja Bouliotis, George Ranjababu, Kulasegaram Clarke, Amanda Post, Frank A Nelson, Mark Burgess, Laura Tiraboschi, Juan Khoo, Saye Taylor, Steve Ashby, Deborah Winston, Alan Producer: 20191015 In: AIDS (London, England) vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	258.	Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats. [electronic resource] by Inan, Saadet Watson, Mia N Doura, Menahem Tallarida, Christopher S Meissler, Joseph J Chen, Xiaohong Geller, Ellen B Cowan, Alan Rawls, Scott M Eisenstein, Toby K Adler, Martin W Producer: 20190603 In: British journal of anaesthesia vol. 122 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	259.	Maraviroc, a CCR5 coreceptor antagonist that blocks entry of human immunodeficiency virus type 1. [electronic resource] by Hunt, Joshua S Romanelli, Frank Producer: 20090420 In: Pharmacotherapy vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	260.	How will CCR5 antagonists influence the recommendations for the antiretroviral treatment of HIV-1 infection. [electronic resource] by van Lunzen, Jan Producer: 20071226 In: European journal of medical research vol. 12 Availability: No items available. Save to lists Add to cart (remove)

First
Previous
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 688 results.